Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.23 EX-3.23(B)
- 3.29 EX-3.29(B)
- 3.29 EX-3.29(C)
- 3.30 EX-3.30(B)
- 3.30 EX-3.30(D)
- 3.39 EX-3.39(B)
- 3.41 EX-3.41(B)
- 3.42 EX-3.42(B)
- 3.42 EX-3.42(C)
- 3.42 EX-3.42(D)
- 3.43 EX-3.43(A)
- 3.43 EX-3.43(B)
- 3.46 EX-3.46
- 3.47 EX-3.47
- 3.52 EX-3.52
- 3.53 EX-3.53
- 3.76 EX-3.76(A)
- 3.76 EX-3.76(B)
- 3.77 EX-3.77
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 23.1 EX-23.1
- 23.2 EX-23.2
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
Rome Delaware similar filings
- 13 Mar 17 Registration of securities issued in business combination transactions
- 14 May 14 Registration of securities issued in business combination transactions (amended)
- 25 Mar 14 Registration of securities issued in business combination transactions
- 18 May 07 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on FormS-4 of our report dated February 22, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Westlake Chemical Corporation’s Annual Report on Form10-K for the year ended December 31, 2016. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Houston, Texas
March 13, 2017